 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Edwards Lifesciences stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:EW! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Edwards Lifesciences stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient’s physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Volume médio
2.71 million shs
MERCADO CAP
$53.67 billion
Bolsa de Valores
NYSE
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NYSE:EW
|
Aparelhos e materiais cirúrgicos
|
Médico
|
33,442 shs
|
Below is a quick guide on how to buy NYSE:EW stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Edwards Lifesciences shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Edwards Lifesciences – Search for “”NYSE:EW”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Edwards Lifesciences stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
20 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Edwards Lifesciences in the last year. There are currently 2 sell ratings, 6 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Edwards Lifesciences stock.
Wall Street analysts have given Edwards Lifesciences a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Edwards Lifesciences wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:EW stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Edwards Lifesciences stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Edwards Lifesciences stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NYSE:EW stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NYSE:EW stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:EW is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Edwards Lifesciences stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Edwards Lifesciences is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for Edwards Lifesciences.
Edwards Lifesciences Co. (NYSE:EW) announced its quarterly earnings data on Tuesday, January, 26th. The medical research company reported $0.50 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by $0.03. The medical research company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Edwards Lifesciences had a trailing twelve-month return on equity of 29.00% and a net margin of 18.18%. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.46 EPS.
View Edwards Lifesciences’ earnings history.
Edwards Lifesciences’ stock was trading at $65.79 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EW stock has increased by 30.7% and is now trading at $86.00.
Edwards Lifesciences shares split before market open on Friday, May 29th 2020. The 3-1 split was announced on Thursday, May 7th 2020. The newly created shares were payable to shareholders after the market closes on Monday, May 18th 2020. An investor that had 100 shares of Edwards Lifesciences stock prior to the split would have 300 shares after the split.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:EW stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
Edwards Lifesciences updated its FY21 earnings guidance on Wednesday, January, 27th. The company provided EPS guidance of $2.00-2.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.13. The company issued revenue guidance of $4.90-5.30 billion, compared to the consensus revenue estimate of $5.10 billion.
20 brokers have issued 12-month target prices for Edwards Lifesciences’ stock. Their forecasts range from $51.67 to $111.00. On average, they expect Edwards Lifesciences’ share price to reach $91.12 in the next year. This suggests a possible upside of 6.0% from the stock’s current price.
View analysts’ price targets for Edwards Lifesciences or view top-rated stocks among Wall Street analysts.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Edwards Lifesciences’ management team includes the following people:
Mr. Michael A. Mussallem, Chairman & CEO (Age 68, Pay $3.64M)
Mr. Scott B. Ullem, Corp. VP & CFO (Age 54, Pay $1.42M)
Mr. Donald E. Bobo Jr., Corp. VP of Strategy & Corp. Devel. (Age 59, Pay $1.36M)
Mr. Larry L. Wood, Corp. VP of Transcatheter Aortic Valve Replacement (Age 55, Pay $1.46M)
Mr. Jean-Luc Lemercier, Corp. VP of Europe, Middle East, Africa, Canada & Latin America (Age 64, Pay $1.33M)
Dr. Todd J. Brinton, Corp. VP of Advanced Technology & Chief Scientific Officer
Mark Wilterding, VP of Investor Relations
Mr. Arnold A. Pinkston, Corp. VP & Gen. Counsel (Age 62)
Mr. Dirksen J. Lehman, Corp. VP of Public Affairs
Ms. Christine Z. McCauley, Corp. VP of HR (Age 56)
389 employees have rated Edwards Lifesciences CEO Michael A. Mussallem on Glassdoor.com. Michael A. Mussallem has an approval rating of 90% among Edwards Lifesciences’ employees.
Some companies that are related to Edwards Lifesciences include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of EW’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Edwards Lifesciences investors own include NVIDIA (NVDA), Alibaba Group (BABA), The Home Depot (HD), salesforce.com (CRM), The Walt Disney (DIS), Visa (V), Johnson & Johnson (JNJ), QUALCOMM (QCOM), Micron Technology (MU) and CVS Health (CVS).
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
Edwards Lifesciences trades on the New York Stock Exchange (NYSE) under the ticker symbol “EW.”
Edwards Lifesciences’ stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.40%), FMR LLC (1.41%), Fisher Asset Management LLC (0.90%), Sumitomo Mitsui Trust Holdings Inc. (0.60%), Jennison Associates LLC (0.42%) and Swiss National Bank (0.38%). Company insiders that own Edwards Lifesciences stock include Catherine M Szyman, Donald E Bobo Jr, Huimin Wang, Jean-Luc M Lemercier, Larry L Wood, Michael A Mussallem, Nicholas J Valeriani, Robert WA Sellers, Schack Wesley W Von, Scott B Ullem and William J Phd Link.
View institutional ownership trends for Edwards Lifesciences.
EW stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Jennison Associates LLC, BlackRock Inc., Frontier Capital Management Co. LLC, NorthCoast Asset Management LLC, Robeco Institutional Asset Management B.V., Swiss National Bank, and California Public Employees Retirement System. Company insiders that have sold Edwards Lifesciences company stock in the last year include Catherine M Szyman, Donald E Bobo Jr, Huimin Wang, Jean-Luc M Lemercier, Larry L Wood, Michael A Mussallem, Nicholas J Valeriani, Robert WA Sellers, and Scott B Ullem.
View insider buying and selling activity for Edwards Lifesciences or view top insider-selling stocks.
EW stock was acquired by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Ardevora Asset Management LLP, Fisher Asset Management LLC, Retirement Systems of Alabama, Russell Investments Group Ltd., UMB Bank N A MO, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, and PGGM Investments.
View insider buying and selling activity for Edwards Lifesciences or or view top insider-buying stocks.
Shares of EW can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of EW stock can currently be purchased for approximately $86.00.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How to buy Edwards Lifesciences stocks?
The safest and easiest way to buy NYSE:EW stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Abrir uma conta com um desses corretores é uma atitude inteligente, eles estão ativos há mais de dez anos, são muito seguros de usar e têm a melhor plataforma para comerciantes novatos e experientes. Se o senhor quiser saber mais, sugerimos-lhe que leia nossa carta de eToro ou DeGiro guias.
Where to buy Edwards Lifesciences stock?
You will first want to find a licensed broker that supports Edwards Lifesciences stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:EW stocks in a safe and complete environment.
Is NYSE:EW stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:EW stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Edwards Lifesciences stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:EW is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Edwards Lifesciences stock.
How do you trade Edwards Lifesciences stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Edwards Lifesciences stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:EW stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Edwards Lifesciences stock?
To sell your NYSE:EW stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Edwards Lifesciences stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:EW stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
